Skip to main content
Fig. 1 | Retrovirology

Fig. 1

From: HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4+ T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial

Fig. 1

CONSORT flow diagram. The number of participants screened, enrolled, randomized, followed-up and analyzed is shown for vaccine and placebo groups. Two hundred participants were randomised to one of the two treatment groups and analyzed for safety (safety population). One subject who received only one immunization was excluded from the immunogenicity population (total = 199). Thirteen volunteers were excluded from the “Per protocol” analysis: four received <3 immunizations, four did not complete three or more visits of follow-up and five had major protocol non-compliance (total = 187)

Back to article page

Retrovirology

ISSN: 1742-4690

Contact us